Cargando…
Neutralization of Botulinum Neurotoxin by a Human Monoclonal Antibody Specific for the Catalytic Light Chain
BACKGROUND: Botulinum neurotoxins (BoNT) are a family of category A select bioterror agents and the most potent biological toxins known. Cloned antibody therapeutics hold considerable promise as BoNT therapeutics, but the therapeutic utility of antibodies that bind the BoNT light chain domain (LC),...
Autores principales: | Adekar, Sharad P., Takahashi, Tsuyoshi, Jones, R. Mark, Al-Saleem, Fetweh H., Ancharski, Denise M., Root, Michael J., Kapadnis, B. P., Simpson, Lance L., Dessain, Scott K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515629/ https://www.ncbi.nlm.nih.gov/pubmed/18714390 http://dx.doi.org/10.1371/journal.pone.0003023 |
Ejemplares similares
-
Enhanced Neutralization Potency of Botulinum Neurotoxin Antibodies
Using a Red Blood Cell-Targeting Fusion Protein
por: Adekar, Sharad P., et al.
Publicado: (2011) -
RBC Adherence of Immune Complexes Containing Botulinum Toxin Improves Neutralization and Macrophage Uptake
por: Al-Saleem, Fetweh H., et al.
Publicado: (2017) -
Recombinant rabies virus particles presenting botulinum neurotoxin antigens elicit a protective humoral response in vivo
por: Hudacek, Andrew W, et al.
Publicado: (2014) -
Use of Monoclonal Antibodies in the Sensitive Detection and Neutralization of Botulinum Neurotoxin Serotype B
por: Cheng, Luisa W., et al.
Publicado: (2015) -
Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B
por: Matsumura, Takuhiro, et al.
Publicado: (2020)